DBV Technologies (DBVT) Depreciation & Amortization (CF) (2020 - 2026)
DBV Technologies (DBVT) posted quarterly Depreciation & Amortization (CF) of $600000.0 for Q2 2026, down 14.29% year-on-year from $700000.0 in Q2 2025, and down 33.33% on a QoQ basis from $900000.0 in Q1 2026.
DBV Technologies (DBVT) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $600000.0 the latest figure, recorded in Q2 2026.
- Quarterly Depreciation & Amortization (CF) fell 14.29% year-over-year to $600000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.0 million (up 36.96% YoY) and the FY2025 annual result came in at $3.2 million, up 445.3% from the prior year.
- Depreciation & Amortization (CF) slipped to $600000.0 in Q2 2026 per DBVT's latest filing, from $900000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for DBVT reached as high as $12.0 million in Q4 2022 and fell as low as -$10.9 million in Q4 2023.
- A 5-year average of $162944.4 and a median of $598500.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) tumbled 3056.88% — and 2025, when it soared 1786.79%.
- Year by year, Depreciation & Amortization (CF) stood at $12.0 million in 2022, then slumped by 190.88% to -$10.9 million in 2023, then jumped by 105.84% to $638000.0 in 2024, then increased by 8.15% to $690000.0 in 2025, then dropped by 13.04% to $600000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $600000.0, $900000.0, and $690000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 600,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 600,000.00 |
| Jun 30, 2026 | 600,000.00 |
| Mar 31, 2026 | 900,000.00 |
| Mar 31, 2026 | 900,000.00 |
| Dec 31, 2025 | 690,000.00 |
| Dec 31, 2025 | 690,000.00 |
| Sep 30, 2025 | 804,000.00 |
| Sep 30, 2025 | 804,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 638,000.00 |
| Dec 31, 2024 | 638,000.00 |
| Sep 30, 2024 | -152,000.00 |
| Sep 30, 2024 | -152,000.00 |
| Jun 30, 2024 | -1.46 Mn |
| Jun 30, 2024 | -1.46 Mn |
| Mar 31, 2024 | 53,000.00 |
| Mar 31, 2024 | 53,000.00 |